Nationwide Fund Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Nationwide Fund Advisors’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-19,730	Closed	-$834K	–	3329
2015 Q2	$834K	Sell	19,730 -36,743	-65%	-$1.55M	﹤0.01%	1960
2015 Q1	$2.19M	Buy	56,473 +6,873	+14%	+$265K	0.01%	1423
2014 Q4	$1.67M	Buy	49,600 +7,560	+18%	+$267K	0.01%	1514
2014 Q3	$1.47M	Buy	+42,040	New	+$1.44M	0.01%	1613
2014 Q2	–	Sell	-53,240	Closed	-$1.96M	–	3439
2014 Q1	$1.96M	Sell	53,240 -32,090	-38%	-$1.18M	0.01%	1361
2013 Q4	$3.27M	Sell	85,330 -3,550	-4%	-$112K	0.01%	1184
2013 Q3	$2.44M	Sell	88,880 -43,430	-33%	-$1.03M	0.01%	1302
2013 Q2	$2.78M	Buy	+132,310	New	+$2.58M	0.01%	1118

Other funds holding WX

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Nationwide Fund Advisors's WX Position: Q3 2015 in Review

Nationwide Fund Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 19,730 shares — an estimated $834K sold.

Nationwide Fund Advisors first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $3.27M in Q4 2013. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

Nationwide Fund Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
Nationwide Fund Advisors sold 19,730 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $834K.
Nationwide Fund Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
Nationwide Fund Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $3.27M in Q4 2013.
151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Nationwide Fund Advisors's 13F filing for Q3 2015, filed 26 Oct 2015.